Tatchempharmpreparaty
CompanyRussia
Tatchempharmpreparaty develops one asset, in phase 3 (Dimephosphon in acute stroke). Mostly small molecule; based in Russia.
- 1
- Asset
- Furthest stage
- Phase 3
- 1
- Trial
- 0
- Signals
Pipeline
1Regulates acid-base balance and cerebral hemodynamics in ischemic stroke
Phase 3, Small molecule, acute stroke, cerebrovascular disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Similar companies6